Use of Minipig Skin Biopsy Model as an Innovative Tool to Design Topical Formulation to Achieve Desired Pharmacokinetics in Humans-Reference-Cited by-同舟云学术

Use of Minipig Skin Biopsy Model as an Innovative Tool to Design Topical Formulation to Achieve Desired Pharmacokinetics in Humans

Published:2015-05 Issue:5 Volume:104 Page:1701-1708
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Mitra Amitava,Leyes Aquiles,Manser Kimberly,Roadcap Brad,Mestre Christine,Tatosian Daniel,Jin Lan,Uemura Naoto

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference25 articles.

1. Update on the therapeutic potential of PDE4 inhibitors;Montana;Expert Opin Investig Drugs,2002

2. Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis;Baumer;Inflamm Allergy Drug Targets,2007

3. Trial watch: PDE4 inhibitor leads wave of target-specific oral psoriasis drugs;Harrison;Nat Rev Drug Discov,2013

4. Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases;Wittmann;Dermatol Ther (Heidelb),2013

5. A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology;Moustafa;Dermatol Online J,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gas Plasma-Augmented Wound Healing in Animal Models and Veterinary Medicine;Molecules;2021-09-19

2. Discovery of a novel RORγ antagonist with skin-restricted exposure for topical treatment of mild to moderate psoriasis;Scientific Reports;2021-04-28

3. Simultaneous determination of tazarotene, clindamycin phosphate and their active metabolites in Bama mini-pig skin by LC-MS/MS: Application to the development of a tazarotene/clindamycin phosphate cream;Journal of Chromatography B;2021-01

4. Local Transdermal Delivery of Telapristone Acetate Through Breast Skin, Compared With Oral Treatment: A Randomized Double‐Blind, Placebo‐Controlled Phase II Trial;Clinical Pharmacology & Therapeutics;2020-10-25

5. Advances in selecting appropriate non-rodent species for regulatory toxicology research: Policy, ethical, and experimental considerations;Regulatory Toxicology and Pharmacology;2020-10